Clinical Trials Directory

Trials / Unknown

UnknownNCT04470102

Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy

A Randomised Controlled Pilot Trial: Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Meshalkin Research Institute of Pathology of Circulation · Network
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Objective of the study: to evaluate whether edge-to-edge technique improves clinical and hemodynamic results in patients scheduled to septal myectomy for severely symptomatic hypertrophic obstructive cardiomyopathy.

Detailed description

A randomised controlled pilot trial to evaluate whether edge-to-edge technique improves clinical and hemodynamic results in patients scheduled to septal myectomy for severely symptomatic hypertrophic obstructive cardiomyopathy. Patients with proven hypertrophic cardiomyopathy and resting left ventricle outflow tract obstruction underwent septal myectomy. If patients were suitable for both surgical techniques, they were randomized to septal myectomy + edge-to-edge mitral valve repair or isolated septal myectomy. All surgeons were experienced at least 50 related procedures.

Conditions

Interventions

TypeNameDescription
PROCEDUREmitral valve repair by edge-to-edge techniquetransaortic access for mitral valve repair edge-to-edge
PROCEDURESeptal myectomyisolated extended septal myectomy

Timeline

Start date
2020-03-12
Primary completion
2021-01-31
Completion
2022-01-31
First posted
2020-07-14
Last updated
2020-07-21

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT04470102. Inclusion in this directory is not an endorsement.